Protein kinase C signal transduction regulation in physiological and pathological aging

Annals of the New York Academy of Sciences

Volumn 1057, Issue , 2005, Pages 177-192

  Battaini, Fiorenzo ^a,c   Pascale, Alessia ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Aging; Alzheimer's disease; Anchoring; Brain; Isoforms; Isozymes; Pineal transplant; PKC; Protein kinase C; RACK1; Scaffolding; Translocation

Indexed keywords

ADAPTOR PROTEIN; ION CHANNEL; ISOENZYME; PROTEIN KINASE C; RECEPTOR; RECEPTOR FOR ACTIVATED C KINASE 1; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; BRAIN FUNCTION; CELL COMMUNICATION; CELL FUNCTION; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME LOCALIZATION; HUMAN; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOLOGY; PHYSIOLOGY; PINEAL BODY; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SURVIVAL;

RODENTIA;

EID: 32244440146     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1356.011     Document Type: Conference Paper

References (72)

1. BATTAINI, F. et al. 1997. The role of anchoring protein RACK1 in PKC activation in the aging rat brain. Trends Neurosci. 20: 410-415.
2. WICKELGREN, I. 1996. For the cortex, neuron loss may be less than thought. Science 273: 48-50.
3. RAPP P.R. & M. GALLAGER. 1996. Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proc. Natl. Acad. Sci. USA 93: 9926-9930.
4. NOGUES, X. et al. 2003. Protein Kinase C. In Memories Are Made of These: From messengers to molecules. G. Riedel & B. Platt, Eds.: 383-410: Landes Bioscience. Georgetown, TX.
5. AMADIO, M. et al. 2004. Emerging targets for the pharmacology of learning and memory. Pharmacol. Res. 50: 111-122.
6. NISHIZUKA, Y. 2003. Discovery and prospect of protein kinase C research: epilogue. J. Biochem. (Tokyo). 133: 155-158.
7. TANAKA, C. & Y. NISHIZUKA. 1994. The protein kinase C family for neuronal signalling. Ann. Rev. Neurosci. 17: 551-567.
8. NEWTON, A.C. 2003. Regulation of the ABC kinases by phosphorylation: PKC as a paradigm. Biochem. J. 370: 361-371.
9. PAREKH, D.B., W. ZIEGLER & P.J. PARKER. 2000. Multiple pathways control PKC phosphorylation. EMBO J. 19: 496-503.
10. RYKX, A. et al. 2003. Protein kinase D: a family affair. FEBS Lett. 546: 81-86.
11. BALENDRAN, A. et al. 2000. Further evidence that 3-phosphoinositide- dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett. 484: 217-223.
12. NISHIZUKA, Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 7: 484-496.
13. POOLE, A.W. et al. 2004. PKC-interacting proteins: from function to pharmacology. Trends Pharmacol. Sci. 25: 528-535.
14. MOCHLY-ROSEN, D. 1995. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 268: 247-251.
15. RON, D. et al. 1994. Cloning of an intracellular receptor for protein kinase C: a homolog of beta subunit of G proteins. Proc. Natl. Acad. Sci. USA 91: 839-843.
16. CSUKAI, M. et al. 1997. The coatomer protein β′-COP, a selective binding protein (RACK) for protein kinase C epsilon. J. Biol. Chem. 272: 29200-29206.
17. MCCAHILL, A. et al. 2002. The RACK1 scaffold protein: a dynamic cog in cell response mechanisms: Mol. Pharmacol. 62: 1261-1273.
18. SCHECHTMAN, D. & D. MOCHLY-ROSEN. 2001. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20: 6339-6347.
19. CSUKAI, M. & D. MOCHLY-ROSEN. 1999. Pharmacologic modulation of protein kinase C isozymes: the role of RACKs and subcellular localisation. Pharmacol. Res. 39: 253-259.
20. MOCHLY-ROSEN, D. & A. GORDON. 1998. Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J. 12: 35-42.
21. GAO, T. & A.C. NEWTON. 2002. The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C. J. Biol. Chem. 277: 31585-31592.
22. ABELIOVICH, A. et al. 1993. Modified hippocampal long term potentiation in PKC gamma-mutant mice. Cell, 75: 1253-1262.
23. HAYASHI, S. et al. 2005. Involvement of gamma protein kinase C in estrogen-induced neuroprotection against focal brain ischemia through G protein-coupled estrogen receptor. J Neurochem. 93: 883-891.
24. LEITGES, M. et al. 2004. A unique PDZ ligand in PKCα confers induction of cerebellar long-term synaptic depression. Neuron 44: 585-594.
25. WEEBER, E.J. et al 2000. A role for the b isoform of protein kinase C in fear conditioning. J. Neurosci. 20: 5906-5914.
26. HODGE, C.W. et al. 1999. Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKC epsilon. Nat. Neurosci. 2: 245-254.
27. Li, M.X. et al. 2004. The role of the theta isoform of protein kinase C (PKC) in activity-dependent synapse elimination: evidence from the PKC theta knock-out mouse in vivo and in vitro. J. Neurosci. 24: 3762-3769.
28. BRIGHT, R. et al. 2004. Protein kinase C delta mediates cerebral reperfusion injury in vivo. J. Neurosci. 24: 6880-6888.
29. WANG, J. et al. 2004. Cell-specific roles for epsilon and beta1-PKC isozymes in protecting cortical neurons and astrocytes from ischemia-like injury. Neuropharmacology 47: 136-145.
30. SWEITZER, S.M. et al. 2004. Exaggerated nociceptive responses on morphine withdrawal: roles of protein kinase C epsilon and gamma. Pain 110: 281-289.
31. JUNG, Y.S. et al. 2005. Activation of protein kinase C-delta attenuates kainate-induced cell death of cortical neurons. Neuroreport 16: 741-744.
32. KOPONEN, S. et al. 2003. Prevention of NMDA-induced death of cortical neurons by inhibition of protein kinase C zeta. J. Neurochem. 86: 442-450.
33. LI, H.F., D. MOCHLY-ROSEN & J.J. KENDIG. 2005. Protein kinase C gamma mediates ethanol withdrawal hyper-responsiveness of NMDA receptor currents in spinal cord motor neurons. Br. J. Pharmacol. 144: 301-307.
34. CRAIG, N. J. et al. 2001. A candidate gene for human neurodegenerative disorders: a rat PKC gamma mutation causes a Parkinsonian syndrome. Nat. Neurosci. 4: 1061-1062.
35. YABE, I. et al. 2003. Spinocerebellar ataxia type 14 caused by a mutation in PKC gamma. Arch. Neurol. 60: 1749-1751.
36. BATTAINI, F. et al. 1990. Regulation of phorbol ester binding and protein kinase C activity in aged rat brain. Neurobiol. Aging 11: 563-566.
37. MEYER, M. et al. 1994. Effect of peroxidation and aging on rat neocortical Ach release and PKC. Neurobiol. Aging 15: 63-67.
38. BATTAINI, F. et al. 1995. Protein kinase C activity, translocation and conventional isoforms in aging rat brain. Neurobiol. Aging 16: 137-148.
39. FRIEDMAN, E. & H.-Y. WANG. 1989. Effect of age on brain cortical PKC and its mediation of 5-hydroxytryptamine release. J. Neurochem. 52: 187-192.
40. COLOMBO, P.J. & M. GALLAGER. 2002. Individual differences in spatial memory among aged rats are related to hippocampal PKC gamma immunoreactivity. Hippocampus 12: 285-289.
41. PASCALE, A. et al. 1996. Functional impairment in PKC by RACK1 (receptor for activated Kinase C1) deficiency in aged rat brain cortex. J. Neurochem 67: 2471-2477.
42. SANGUINO, E. et al. 2004. Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs. Biochem. Pharmacol. 68: 1411-1421.
43. PASCALE, A., S. GOVONI & F. BATTAINI. 1998. Age-related alteration of PKC, a key enzyme in memory processes. Mol. Neurobiol. 16: 49-62.
44. HARRISON-LAVOIE, K.J. et al. 1993. A 102 kDa subunit of a Golgi associated particle has homology to beta subunits of trimeric G proteins. EMBO J. 12: 2847-2853.
45. BATTAINI, F. 2001. Protein kinase C isoforms as therapeutic targets in nervous system disease states. Pharmacol. Res. 44: 353-361.
46. RACCHI, M. & S. GOVONI. 1999. Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism. Trends Pharmacol. Sci. 20: 418-423.
47. ETCHEBERRIGARAY, R. & S. BHAGAVAN. 1999. Ionic and signal transduction alterations in Alzheimer's disease: relevance of studies on peripheral cells. Mol. Neurobiol. 20: 93-109.
48. WANG, H.-Y, M.R. PISANO & E. FRIEDMAN. 1994. Attenuated PKC activity and translocation in Alzheimer's disease brain. Neurobiol. Aging 15: 293-298.
49. BATTAINI, F. et al. 1999. Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients. Exp. Neurol. 159: 559-564.
50. CORSINI, E. et al. 1999. A defective PKC anchoring system underlying age-associated impairment in TNF-alpha production in rat macrophages. J. Immunol. 163: 3468-3473.
51. KORZICK, D.H. et al. 2001. Diminished alpha 1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart. Am. J. Physiol. Heart Circ. Physiol. 281: H581-H589.
52. CORSINI, E. et al. 2005. Age-related decline in RACK-1 expression in human leukocytes is correlated to plasma levels of dehydroepiandrosterone. J. Leukoc. Biol. 77: 247-255.
53. GIANOTTI, C. et al. 1993. B-50/GAP43 phosphorylation in hippocampal slices from aged rats: effects of phosphatidylserine administration. Neurobiol. Aging 14: 401-406.
54. ECKLES, K.E. et al. 1997. Amelioration of age-related deficits in the stimulation of synapsin phosphorylation. Neurobiol. Aging 18: 213-217.
55. WANG, H.-Y. et al. 2000. Age-related decreases in lymphocyte protein kinase C activity and translocation are reduced by aerobic fitness. J. Gerontol. A Biol. Sci. Med. Sci. 55: B545-555
56. KORZICK, D.H. et al. 2004. Chronic exercise improves myocardial inotropic reserve capacity through alpha1-adrenergic and protein kinase C-dependent effects in senescent rats. J. Gerontol. A Biol. Sci. Med. Sci. 59: 1089-1099.
57. RACCHI, M. et al. 2001. Dehydroepiandrosterone and the relationship with aging and memory: a possible link with protein kinase C functional machinery. Brain Res. Rev. 37: 287-293.
58. CORSINI, E. et al. 2002. In vivo dehydroepiandrosterone restores age-associated defects in PKC signal transduction pathway and related functional responses. J. Immunol. 168: 1753-1758.
59. PIERPAOLI, W. & W. REGELSON. 1994. Pineal control of aging: effect of melatonin and pineal grafting on aging mice. Proc. Natl. Acad. Sci. USA 91: 787-791.
60. VITICCHI, C. et al. 1994. Brain cortex alpha and beta adrenoceptors are differentially modulated by pineal graft in aging mice. Ann. N.Y. Acad. Sci. 719: 448-453.
61. PIERPAOLI, W. et al. 1997. Circadian melatonin and young to old pineal grafting postpone aging and maintain juvenile conditions of reproductive functions in mice and rats. Exp. Gerontol. 32: 587-602.
62. VAN DER ZEE, E.A., P.G. LUITEN & J.F. DISTERHOFT. 1997. Learning-induced alterations in hippocampal PKC-gamma immunoreactivity: a review and hypothesis of its functional significance. Prog. Neuropsychopharmacol. Biol. Psych. 3: 531-572.
63. PEYRL, A. et al. 2002. Aberrant expression of signalling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21). Electrophoresis 23: 152-157.
64. VAN DER ZEE, E.A. et al. 2004. Aging-related alterations in the distribution of Ca(2+)-dependent PKC isoforms in rabbit hippocampus. Hippocampus 14: 849-860.
65. ESCRIBA, P.V. & J.A. GARCIA-SEVILLA. 1999. Parallel modulation of receptor for activated C kinase 1 and protein kinase C-alpha and beta isoforms in brains of morphine-treated rats. Br. J. Pharmacol. 127: 343-348.
66. WANG, H.-Y. & E. FRIEDMAN. 2001. Increased association of brain PKC with the receptor for activated C kinase 1 (RACK1) in bipolar affective disorder. Biol. Psych. 50: 364-370.
67. CHOI, D.-S. et al. 2003. The mouse RACK1 gene is regulated by nuclear factor-kB and contributes to cell survival. Mol. Pharmacol. 64: 1541-1548.
68. KALTSCHMIDT, B. et al. 1999. Inhibition of NF-kappa B potentiates amyloid beta-mediated neuronal apoptosis. Proc. Natl. Acad. Sci. USA. 96: 9409-9414.
69. ETCHEBERRIGARAY, R. et al. 2004. Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice. Proc. Natl. Acad. Sci. USA 101: 11141-11146.
70. BAR-AM, O. et al. 2004. Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline, and its derivatives in vivo. J. Neurochem. 89: 1119-1125.
71. WAY, K.J., E. CHOU & G.L. KING. 2000. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21: 181-187.
72. DEMPSEY, E.C. et al. 2000. Protein kinase C isozymes and the regulation of diverse cell responses. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: 429-438.